THE COSTS OF TREATING FEBRILE NEUTROPENIA IN 6 UK HOSPITALS

被引:20
作者
LEESE, B
机构
关键词
D O I
10.1016/0959-8049(93)90611-I
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The cost of treating an episode of febrile neutropenia (FNE) in patients with solid tumours was estimated from the expert opinions of six consultant oncologists in six hospitals in England. Hospital, antibiotic, therapeutic and diagnostic test costs were collected. Hospitalisation, representing 62% of costs, was the largest single factor contributing to the mean cost per FNE of pound 1541. If granulocyte colony-stimulating factor (filgrastim) can reduce the length of stay of such patients, then the savings wilt partly offset the cost of the drug.
引用
收藏
页码:S15 / S18
页数:4
相关论文
共 15 条
[1]   PHASE-I/II STUDY OF RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR IN PATIENTS RECEIVING INTENSIVE CHEMOTHERAPY FOR SMALL CELL LUNG-CANCER [J].
BRONCHUD, MH ;
SCARFFE, JH ;
THATCHER, N ;
CROWTHER, D ;
SOUZA, LM ;
ALTON, NK ;
TESTA, NG ;
DEXTER, TM .
BRITISH JOURNAL OF CANCER, 1987, 56 (06) :809-813
[2]  
CHAPLIN S, 1991, HOSPITAL DOCTOR 0530, P30
[3]   REDUCTION BY GRANULOCYTE COLONY-STIMULATING FACTOR OF FEVER AND NEUTROPENIA INDUCED BY CHEMOTHERAPY IN PATIENTS WITH SMALL-CELL LUNG-CANCER [J].
CRAWFORD, J ;
OZER, H ;
STOLLER, R ;
JOHNSON, D ;
LYMAN, G ;
TABBARA, I ;
KRIS, M ;
GROUS, J ;
PICOZZI, V ;
RAUSCH, G ;
SMITH, R ;
GRADISHAR, W ;
YAHANDA, A ;
VINCENT, M ;
STEWART, M ;
GLASPY, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (03) :164-170
[4]  
Faulds D, 1992, Pharmacoeconomics, V1, P231
[5]  
FINCHY SC, 1986, HAEMATOLOGY, P773
[6]  
GLASPY JA, 1991, CLIN RES, V39, pA7
[7]  
GREEN JA, 1991, P AM SOC CLIN ONCOL, V10
[8]  
GURNEY H, 1989, CLINICIAN, V7, P2
[9]   RECOMBINANT GRANULOCYTE COLONY-STIMULATING FACTOR (RG-CSF) - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND PROSPECTIVE ROLE IN NEUTROPENIC CONDITIONS [J].
HOLLINGSHEAD, LM ;
GOA, KL .
DRUGS, 1991, 42 (02) :300-330
[10]  
LEESE B, 1990, MED LAB SCI, V47, P256